Quantification of the Endogenous Growth Hormone and Prolactin Lowering Effects of a Somatostatin-Dopamine Chimera Using Population PK/PD Modeling

Journal of Pharmacokinetics and Pharmacodynamics - United States
doi 10.1007/s10928-020-09683-3
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Population PK/PD Analysis

2010English

Effects of Methyldopa on Prolactin and Growth Hormone.

BMJ
1976English

Effects of Hypophysectomy, Prolactin, and Growth Hormone on Growth of Postmetamorphic Frogs

General and Comparative Endocrinology
Animal ScienceZoologyEndocrinology
1969English

SOM230, a New Somatostatin Analogue, Is Highly Effective in the Therapy of Growth Hormone/Prolactin-Secreting Pituitary Adenomas

Clinical Cancer Research
Cancer ResearchOncology
2007English

Acute Effects of Lithium on Central Dopamine and Serotonin Activity Reflected by Inhibition of Prolactin and Growth Hormone Secretion in the Rat

Australian Journal of Biological Sciences
1979English

In Vitro Simultaneous Release of Endogenous Somatostatin and Growth Hormone From Human Adenomatous Pituitary Cells

Pediatric Research
Child HealthPediatricsPerinatology
1986English

Population Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Depot Testosterone Cypionate in Healthy Male Subjects

English

Growth Hormone and Prolactin Concentrations in Plasma of Horses: Sex Differences and the Effects of Acute Exercise and Administration of Growth Hormone-Releasing Hormone.

Journal of Animal Science
Animal ScienceZoologyGeneticsMedicineFood Science
1994English

Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Anti-Neoplastic Agents

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy